Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Lubniewski John L Create: Alert

All | News | Filings
Date FiledTypeDescription
12/13/2022 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 1,000 shares @ $0.425, valued at $425
08/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Paid exercise price by delivering 62 shares @ $1.39, valued at $86.2
12/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2020 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 66 shares @ $4.8705, valued at $321.5
10/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2020 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 1,200,000 options to buy @ $0.48, valued at $576k
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 1,000 shares @ $0.5525, valued at $552.5
04/02/2020 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Paid exercise price by delivering 1,086 shares @ $0.33, valued at $358.4
01/27/2020 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 537,500 options to buy @ $0.66, valued at $354.8k
01/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2019 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 701 shares @ $0.5656, valued at $396.5
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2019 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 112,500 options to buy @ $0.95, valued at $106.9k
07/03/2019 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Paid exercise price by delivering 921 shares @ $1.66, valued at $1.5k
06/13/2019 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 761 shares @ $1.5725, valued at $1.2k
05/24/2019 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 300,000 options to buy @ $2.22, valued at $666k
04/01/2019 4 Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Paid exercise price by delivering 909 shares @ $2.5, valued at $2.3k
01/02/2019 4 Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Paid exercise price by delivering 921 shares @ $2.54, valued at $2.3k
12/17/2018 4 Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Acquired 735 shares @ $1.5725, valued at $1.2k
10/02/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2018 4 Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 50,000 shares @ $0
Granted 100,000 options to buy @ $3.4, valued at $340k
06/14/2018 4 Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Acquired 788 shares @ $1.5725, valued at $1.2k
01/31/2018 4 Lubniewski John L (SVP, Chief Business Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Granted 63,483 shares @ $0
12/15/2017 4 Lubniewski John L (Chief Business Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns: Acquired 818 shares @ $1.6065, valued at $1.3k
07/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy